Open navigation
Search
Search
All expertise
Explore our breadth of expertise.
International Desks
Helping you access overseas markets with support from our country and region-specific experts
Sectors View all
Practice Areas View all
Offices
Discover the scope of our presence in the jurisdiction.
Global Reach
Learn about our capabilities beyond borders.
CMS France
All insights
Leverage our expert analysis, intelligence and thought leadership for your strategic advantage.
Personalised updates
Receive tailored insights and intelligence that apply directly to your business.
Topics in focus View all
Insights by type
CMS News
Stay up to date with our growth, evolution and our many successes.
Contact us
For all general enquiries.
About CMS
CMS Careers

Select your region

International Europe Africa Asia-Pacific The Americas Middle East
English Français
Press releases

CMS Francis Lefebvre advises GenSight Biologics on a first fundraising in 2026

31 Mar 2026 France 1 min read

On this page

    GenSight Biologics is a biopharmaceutical company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders. Its shares are admitted to trading on Euronext Paris.

    This new fundraising of nearly €1.7 million in total, through the issuance of new shares and warrants (pre-financed or not), is intended to secure its cash requirements and support the preparation of the RECOVER Phase III trial of GS010/LUMEVOQ®, GenSight Biologics' most advanced product candidate, which is currently in Phase III clinical development.

    GenSight Biologics was advised by CMS Francis Lefebvre. The CMS Francis Lefebvre team comprised Bertrand Sénéchal, partner, and Pierre Maunand, associate. CMS Francis Lefebvre already advised GenSight Biologics on four successive fundraisings between June and December 2025.

    More insights
    Banking & Finance

    Explore more

    Newsletter France

    Deals, doubts and divergences: CMS European M&A Outlook 2026

    28 Oct 2025 5 min read
    Event France

    IP Insights webinar series 2026

    28 Apr 2026
    Expert Guide International

    CMS Expert Guide for taking security in France

    31 min read
    Back to top Back to top
    If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.